MedPath

Xenon and Cooling Therapy in Babies at High Risk of Brain Injury Following Poor Condition at Birth

Phase 1
Completed
Conditions
Hypoxic Ischaemic Encephalopathy
Interventions
Device: Whole body cooling
Registration Number
NCT01545271
Lead Sponsor
University Hospitals Bristol and Weston NHS Foundation Trust
Brief Summary

This study examines the effect of inhaled xenon gas in the treatment of newborn infants with hypoxic-ischemic encephalopathy (HIE) in combination with cooling, which is the standard treatment for this condition. The hypothesis is that the xenon + cooling combination will produce better neuroprotection than the standard treatment of cooling alone.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
32
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
72h cooling + 18h xenon inhalationxenon gasBabies in poor condition at birth and referred to our neonatal unit for standard therapy of cooling to 33.5 degree C body temperature will be randomised to receive xenon gas at 50% concentration for 18 hours
72h cooling + 18h xenon inhalationWhole body coolingBabies in poor condition at birth and referred to our neonatal unit for standard therapy of cooling to 33.5 degree C body temperature will be randomised to receive xenon gas at 50% concentration for 18 hours
Standard 72 h whole body cooling therapyWhole body coolingWhole body cooling therapy to rectal temperature of 33.5 degree Centigrade (standard therapy)
Primary Outcome Measures
NameTimeMethod
Death and moderate or severe disability - Bayley IIIat 18 months of age

Bayley Scales of Infant and Toddler Development III (Bayley III) has three domains: cognition, language and motor skills. Each domain is based on a series of examinations of different severity. The lower cut off level is 55 for cognition, 47 for language and 46 for motor. The upper value can be 145. Assessment of hearing and vision: severe hearing loss defined as inability to hear without amplification; severe visual loss defined as being unable to move independently.

Secondary Outcome Measures
NameTimeMethod
Brain MRIless than 2 weeks of age

Magnetic Resonance Imaging findings at less than 2 weeks of age

Amplitude Integrated Electroencephalogram (aEEG) gradingBefore hospital discharge; usually within one week of birth

Number of hours after birth when aEEG voltage has reached a normal or discontinuous normal pattern

Trial Locations

Locations (1)

St Michael's Hospital

🇬🇧

Bristol, Avon, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath